Testing effectiveness (Phase 2)Looking for participantsNCT06401824
What this trial is testing
Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases
Who this might be right for
NSCLC Stage IVBrain Metastases, Adult
Maastricht University Medical Center 25